Enhanced Expression of Transgenes from Adeno-Associated Virus Vectors with the Woodchuck Hepatitis Virus Posttranscriptional Regulatory Element: Implications for Gene Therapy
Abstract
The woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) evolved to stimulate the expression of intronless viral messages. To determine whether this ability to enhance expression could be useful in nonviral and heterologous viral gene delivery systems, we analyzed the ability of the WPRE to elevate the expression of a cDNA encoding the green fluorescent protein (GFP) in these contexts. We find that the WPRE can stimulate the expression of GFP when the gene is delivered by transfection or transduction with recombinant adeno-associated virus (AAV). Enhancement occurred both during transient expression and when the gene is stably incorporated into the genome of target cells. This enhancement required that the WPRE be located in cis within the GFP message, and was observed in both transformed cell lines and primary human fibroblasts. These results demonstrate that the WPRE will be an effective tool for increasing the long-term expression of transgenes in gene therapy.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
WPRE contributes to strong expression of transgenes in AAV systems.
“WPRE is a 600 bp long tripartite element containing gamma, alpha, and beta elements, in the given order [16] and contributes to the strong expression of transgenes in AAV systems [11-13].”
From Optimization of AAV expression cassettes to improve packaging capacity and transgene expression in neurons (2014) · cites this paper as [11]
WPRE is often included in AAV cassettes to improve viral titer and transduction efficiency via stabilizing mRNA and regulating transcriptional termination.
“The woodchuck hepatitis post-transcriptional regulatory element (WPRE) is often included in AAV cassettes to improve viral titer and transduction efficiency via stabilizing mRNA and regulating transcriptional termination [26, 27].”
From Designing and optimizing AAV-mediated gene therapy for neurodegenerative diseases: from bench to bedside (2024) · cites this paper as [26]
Cites
Tsien, R. Y. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.509 · Cited by 6,178 · see citing works
Xiao, X., Li, J., & Samulski, R. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.3.2224-2232.1998 · Cited by 1,381 · see citing works
Malim, M. H., Hauber, J., Le, S.-Y., Maizel, J. V., & Cullen, B. R. (1989) · Nature · doi:10.1038/338254a0 · Cited by 1,280 · see citing works
Zufferey, R., Donello, J. E., Trono, D., & Hope, T. J. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2886-2892.1999 · Cited by 1,012 · see citing works
Self-citationXiao, X., Li, J., & Samulski, R. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.11.8098-8108.1996 · Cited by 913 · see citing works
Samulski, R. J., Chang, L., & Shenk, T. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.9.3822-3828.1989 · Cited by 742 · see citing works
Quantitative analysis of the packaging capacity of recombinant adeno-associated virus
Dong, J.-Y., Fan, P.-D., & Frizzell, R. A. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.17-2101 · Cited by 583 · see citing works
Snyder, R. O., Miao, C. H., Patijn, G. A., Spratt, S. K., Danos, O., Nagy, D., Gown, A. M., Winther, B., Meuse, L. A., Cohen, L. K., et al. (1997) · Nature Genetics · doi:10.1038/ng0797-270 · Cited by 579 · see citing works
Fisher, K. J., Gao, G. P., Weitzman, M. D., DeMatteo, R. P., Burda, J. F., & Wilson, J. M. (1996) · Journal of Virology · doi:10.1128/jvi.70.1.520-532.1996 · Cited by 546 · see citing works
Self-citationFlotte, T. R., Afione, S. A., Conrad, C., McGrath, S. A., Solow, R., Oka, H., Zeitlin, P. L., Guggino, W. B., & Carter, B. J. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.22.10613 · Cited by 490 · see citing works
Samulski, R. J., Chang, L., & Shenk, T. E. (1987) · Journal of Virology · doi:10.1128/jvi.61.10.3096-3101.1987 · Cited by 449 · see citing works
Comparison of Intron-Dependent and Intron-Independent Gene Expression
Buchman, A. R., & Berg, P. R. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.10.4395-4405.1988 · Cited by 370 · see citing works
A Generic Intron Increases Gene Expression in Transgenic Mice
Choi, T., Huang, M. T. F., Gorman, C., & Jaenisch, R. (1991) · Molecular and Cellular Biology · doi:10.1128/mcb.11.6.3070 · Cited by 356 · see citing works
Woodchuck hepatitis virus contains a tripartite posttranscriptional regulatory element
Donello, J. E., Loeb, J. E., & Hope, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.6.5085-5092.1998 · Cited by 350 · see citing works
Self-citationAdeno-associated virus general transduction vectors: analysis of proviral structures
McLaughlin, S. K., Collis, P., Hermonat, P. L., & Muzyczka, N. (1988) · Journal of Virology · doi:10.1128/jvi.62.6.1963-1973.1988 · Cited by 348 · see citing works
Cheung, A. K., HOGGAN, M. D., Hauswirth, W. W., & Berns, K. I. (1980) · Journal of Virology · doi:10.1128/jvi.33.2.739-748.1980 · Cited by 287 · see citing works
Adeno-associated virus vectors in gene therapy
Kamieniarz-Gdula, K., & Goździcka‐Józefiak, A. (2005) · Biotechnologia · Cited by 253 · see citing works
Evidence that HIV‐1 Rev directly promotes the nuclear export of unspliced RNA.
Fischer, U., Meyer, S., Teufel, M., Heckel, C. D. D. S. C. , Lührmann, R., & Rautmann, G. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06728.x · Cited by 246 · see citing works
Pasquinelli, A. E., Ernst, R. K., Lund, E., Grimm, C., Zapp, M. L., Rekosh, D., Hammarskjöld, M., & Dahlberg, J. E. (1997) · The EMBO Journal · doi:10.1093/emboj/16.24.7500 · Cited by 239 · see citing works
Prospects for the Use of Adeno-Associated Virus as a Vector for Human Gene Therapy
Kotin, R. M. (1994) · Human Gene Therapy · doi:10.1089/hum.1994.5.7-793 · Cited by 238 · see citing works
Gene Transfer by Adeno-Associated Virus Vectors into the Central Nervous System
Xiao, X., Li, J., McCown, T. J., & Samulski, R. J. (1997) · Experimental Neurology · doi:10.1006/exnr.1996.6396 · Cited by 202 · see citing works
Saavedra, C., Felber, B. K., & Izaurralde, E. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00288-0 · Cited by 169 · see citing works
Adeno-associated virus vectors
Carter, B. J. (1992) · Current Opinion in Biotechnology · doi:10.1016/0958-1669(92)90082-t · Cited by 160 · see citing works
Huang, Z., & Yen, T. S. B. (1995) · Molecular and Cellular Biology · doi:10.1128/mcb.15.7.3864 · Cited by 149 · see citing works
Murphy, J. E., Zhou, S., Giese, K., Williams, L. T., Escobedo, J. A., & Dwarki, V. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.25.13921 · Cited by 122 · see citing works
Huang, Z., & Yen, T. S. B. (1994) · Journal of Virology · doi:10.1128/jvi.68.5.3193-3199.1994 · Cited by 113 · see citing works
Intronless mRNA transport elements may affect multiple steps of pre‐mRNA processing
Huang, Y., Wimler, K. M., & Carmichael, G. (1999) · The EMBO Journal · doi:10.1093/emboj/18.6.1642 · Cited by 112 · see citing works
Latent infection of KB cells with adeno-associated virus type 2
LAUGHLIN, C. A., Cardellichio, C. B., & Coon, H. (1986) · Journal of Virology · doi:10.1128/jvi.60.2.515-524.1986 · Cited by 106 · see citing works
Ryu, W., & Mertz, J. E. (1989) · Journal of Virology · doi:10.1128/jvi.63.10.4386-4394.1989 · Cited by 105 · see citing works
The hepatitis B virus posttranscriptional regulatory element is composed of two subelements
Donello, J. E., Beeche, A. A., Smith, G. J., Lucero, G. R., & Hope, T. J. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4345-4351.1996 · Cited by 91 · see citing works
Self-citationSequences Within the Last Intron function in RNA 3'-End Formation in Cultured Cells
Nešić, D., Cheng, J., & Maquat, L. E. (1993) · Molecular and Cellular Biology · doi:10.1128/mcb.13.6.3359 · Cited by 91 · see citing works
Antoniou, M. N. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.3.721 · Cited by 90 · see citing works
Scaleable chromatographic purification process for recombinant adeno-associated virus (rAAV)
O’Riordan, C. R., Lachapelle, A., Vincent, K. A., & Wadsworth, S. C. (2000) · The Journal of Gene Medicine · doi:10.1002/1521-2254(200011/12)2:6 · Cited by 70 · see citing works
Smith, G. (1998) · Nucleic Acids Research · doi:10.1093/nar/26.21.4818 · Cited by 44 · see citing works
Wang, J., Zheng, H., Sugahara, Y., Tan, J. J., Yao, S.-N., Olson, E. N., & Kurachi, K. (1996) · Human Gene Therapy · doi:10.1089/hum.1996.7.14-1743 · Cited by 28 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Adeno-associated virus vector as a platform for gene therapy delivery
Wang, D., Tai, P. W. L., & Gao, G. (2019) · Nature Reviews Drug Discovery · doi:10.1038/s41573-019-0012-9 · Cited by 2,444 · see citing works
MacLaren, R. E., Groppe, M., Barnard, A. R., Cottriall, C. L., Tolmachova, T., Seymour, L., Clark, K. R., During, M. J., Cremers, F. P. M., Black, G. C. M., et al. (2014) · The Lancet · doi:10.1016/s0140-6736(13)62117-0 · Cited by 796 · see citing works
Thy1-GCaMP6 transgenic mice for neuronal population imaging in vivo
Dana, H., Chen, T.-W., Hu, A., Shields, B. C., Guo, C., Looger, L. L., Kim, D. S., & Svoboda, K. (2014) · PLoS ONE · doi:10.1371/journal.pone.0108697 · Cited by 574 · see citing works
Gene therapy: twenty-first century medicine.
Verma, I., & Weitzman, M. (2005) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.74.050304.091637 · Cited by 641 · see citing works
Self-citationDemaison, C., Parsley, K. L., Brouns, G. S., Scherr, M., Battmer, K., Kinnon, C., Grez, M., & Thrasher, A. J. (2002) · Human Gene Therapy · doi:10.1089/10430340252898984 · Cited by 477 · see citing works
Pardridge, W. M. (2007) · Pharmaceutical Research · doi:10.1007/s11095-007-9324-2 · Cited by 450 · see citing works
Eisch, A. J., Bolaños, C. A., de Wit, J., Simonak, R. D., Pudiak, C. M., Barrot, M., Verhaagen, J., & Nestler, E. J. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.003 · Cited by 420 · see citing works
Martin, K. R. G., Quigley, H. A., Zack, D. J., Levkovitch-Verbin, H., Kielczewski, J., Valenta, D., Baumrind, L., Pease, M. E., Klein, R. L., & Hauswirth, W. W. (2003) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.02-1332 · Cited by 362 · see citing works
de Boer, A. G., & Gaillard, P. J. (2006) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.47.120505.105237 · Cited by 355 · see citing works
Gene Therapy: Promises and Problems
Pfeifer, A., & Verma, I. M. (2001) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.2.1.177 · Cited by 344 · see citing works
Creation of highly aligned electrospun poly-L-lactic acid fibers for nerve regeneration applications
Wang, H. B., Mullins, M. E., Cregg, J. M., Hurtado, A., Oudega, M., Trombley, M. T., & Gilbert, R. J. (2008) · Journal of Neural Engineering · doi:10.1088/1741-2560/6/1/016001 · Cited by 313 · see citing works
Dopaminergic Cell Loss Induced by Human A30P α -Synuclein Gene Transfer to the Rat Substantia Nigra
Klein, R. L., King, M. A., Hamby, M. E., & Meyer, E. M. (2002) · Human Gene Therapy · doi:10.1089/10430340252837206 · Cited by 209 · see citing works
Recombinant AAV-mediated gene delivery to the central nervous system
Tenenbaum, L., Chtarto, A., Lehtonen, E., Velu, T. J., Brotchi, J., & Levivier, M. (2004) · The Journal of Gene Medicine · doi:10.1002/jgm.506 · Cited by 204 · see citing works
Retroviral Vectors for High-Level Transgene Expression in T Lymphocytes
Engels, B., Çam, H., Schüler, T., Indraccolo, S., Gladow, M., Baum, C., Blankenstein, T. J. F., & Uckert, W. (2003) · Human Gene Therapy · doi:10.1089/104303403322167993 · Cited by 202 · see citing works
Choi, J.-H., Yu, N.-K., Baek, G.-C., Bakes, J., Seo, D., Nam, H. J., Baek, S. H., Lim, C.-S., Lee, Y.-S., & Kaang, B.-K. (2014) · Molecular Brain · doi:10.1186/1756-6606-7-17 · Cited by 197 · see citing works
Schambach, A., Wodrich, H., Hildinger, M., Bohne, J., Kräusslich, H.-G., & Baum, C. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0191 · Cited by 194 · see citing works
Synaptic Specificity and Application of Anterograde Transsynaptic AAV for Probing Neural Circuitry
Zingg, B., Peng, B., Huang, J., Tao, H. W., & Zhang, L. I. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.2158-19.2020 · Cited by 189 · see citing works
Improved method of recombinant AAV2 delivery for systemic targeted gene therapy.
Mah, C., Fraites, T. J., Zolotukhin, I., Song, S.-H., Flotte, T., Dobson, J., Batich, C., & Byrne, B. (2002) · Molecular Therapy · doi:10.1006/mthe.2001.0636 · Cited by 180 · see citing works
Wang, L., Nichols, T. C., Read, M. S., Bellinger, D. A., & Verma, I. M. (2000) · Molecular Therapy · doi:10.1006/mthe.2000.0031 · Cited by 176 · see citing works
Promoters and Control Elements: Designing Expression Cassettes for Gene Therapy
Papadakis, E. D., Nicklin, S. A., Baker, A. H., & White, S. J. (2004) · Current Gene Therapy · doi:10.2174/1566523044578077 · Cited by 169 · see citing works
Franco, L. M., Sun, B., Yang, X., Bird, A., Zhang, H., Schneider, A., Brown, T. T., Young, S. P., Clay, T. M., Amalfitano, A., et al. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.04.024 · Cited by 169 · see citing works
Paterna, J.-C., Moccetti, T., Mura, A., Feldon, J., & Büeler, H. (2000) · Gene Therapy · doi:10.1038/sj.gt.3301221 · Cited by 189 · see citing works
Klein, R. L., Hamby, M. E., Gong, Y., Hirko, A. C., Wang, S., Hughes, J. A., King, M. A., & Meyer, E. M. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7942 · Cited by 160 · see citing works
de Almeida, L. P., Zala, D., Aebischer, P., & Déglon, N. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0388 · Cited by 156 · see citing works
Gene delivery to the eye using adeno-associated viral vectors
Martin, K. R. G., Klein, R. L., & Quigley, H. A. (2002) · Methods · doi:10.1016/s1046-2023(02)00232-3 · Cited by 149 · see citing works
Evaluation of Risks Related to the Use of Adeno-Associated Virus-Based Vectors
Tenenbaum, L., Lehtonen, E., & Monahan, P. E. (2003) · Current Gene Therapy · doi:10.2174/1566523034578131 · Cited by 146 · see citing works
Eaton, M. J., Blits, B., Ruitenberg, M. J., Verhaagen, J., & Oudega, M. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301814 · Cited by 146 · see citing works
Schambach, A., Bohne, J., Baum, C., Hermann, F. G., Egerer, L., von Laer, D., & Giroglou, T. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302698 · Cited by 145 · see citing works
Design of HIV Vectors for Efficient Gene Delivery into Human Hematopoietic Cells
Yam, P. Y., Li, S., Wu, J. C., Hu, J. X., Zaia, J. A., & Yee, J. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0558 · Cited by 142 · see citing works
Blits, B., Carlstedt, T. P., Ruitenberg, M. J., DEWINTER, F., HERMENS, W., Dijkhuizen, P. A., CLAASENS, J., Eggers, R., VANDERSLUIS, R., & Tenenbaum, L. (2004) · Experimental Neurology · doi:10.1016/j.expneurol.2004.05.014 · Cited by 139 · see citing works
Yoshimura, H., Shibata, S. B., Ranum, P. T., & Smith, R. J. (2018) · Scientific Reports · doi:10.1038/s41598-018-21233-z · Cited by 127 · see citing works
Ruitenberg, M. J., Plant, G. W., Christensen, C. L., Blits, B., Niclou, S. P., Harvey, A. R., Boer, G. J., & Verhaagen, J. (2002) · Gene Therapy · doi:10.1038/sj.gt.3301626 · Cited by 124 · see citing works
Blits, B., Oudega, M., Boer, G. J., Bunge, M. B., & Verhaagen, J. (2003) · Neuroscience · doi:10.1016/s0306-4522(02)00970-3 · Cited by 122 · see citing works
HIV-1 Vpr—a still “enigmatic multitasker”
Guenzel, C. A., Hérate, C., & Bénichou, S. (2014) · Frontiers in Microbiology · doi:10.3389/fmicb.2014.00127 · Cited by 119 · see citing works
Glover, C. P. J., Bienemann, A. S., Heywood, D. J., Cosgrave, A. S., & Uney, J. B. (2002) · Molecular Therapy · doi:10.1006/mthe.2002.0588 · Cited by 120 · see citing works
Harvey, A. R., Kamphuis, W., Eggers, R., Symons, N. A., Blits, B., Niclou, S., Boer, G. J., & Verhaagen, J. (2002) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2002.1168 · Cited by 114 · see citing works
Sun, B., Zhang, H., Franco, L. M., Brown, T. T., Bird, A., Schneider, A., & Koeberl, D. D. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.012 · Cited by 111 · see citing works
Methods for Gene Transfer to the Central Nervous System
Kantor, B., Bailey, R. M., Wimberly, K., Kalburgi, S. N., & Gray, S. J. (2014) · Advances in Genetics · doi:10.1016/b978-0-12-800149-3.00003-2 · Cited by 109 · see citing works
Nanoparticle-based technologies for retinal gene therapy
Adijanto, J., & Naash, M. I. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2014.12.028 · Cited by 107 · see citing works
CAR-T cell potency: from structural elements to vector backbone components
Mazinani, M., & Rahbarizadeh, F. (2022) · Biomarker Research · doi:10.1186/s40364-022-00417-w · Cited by 105 · see citing works
Higashimoto, T., Urbinati, F., Perumbeti, A., Jiang, G., Zarzuela, A., Chang, L.-J., Kohn, D. B., & Malik, P. (2007) · Gene Therapy · doi:10.1038/sj.gt.3302979 · Cited by 101 · see citing works
Fitzsimons, H. L., Bland, R. J., & During, M. J. (2002) · Methods · doi:10.1016/s1046-2023(02)00227-x · Cited by 99 · see citing works
Gene therapy: targeting the myocardium
Lyon, A. R., Sato, M., Hajjar, R. J., Samulski, R. J., & Harding, S. E. (2007) · Heart · doi:10.1136/hrt.2007.116483 · Cited by 97 · see citing works
Rahim, A. A., Wong, A. M. S., Hoefer, K., Buckley, S. M. K., Mattar, C. N. Z., Cheng, S. H., Chan, J. K. Y., Cooper, J. D., & Waddington, S. N. (2011) · The FASEB Journal · doi:10.1096/fj.11-182311 · Cited by 95 · see citing works
Helwig, M., Klinkenberg, M., Rusconi, R., Musgrove, R. E., Majbour, N. K., El‐Agnaf, O. M. A., Ulusoy, A., & Monte, D. A. D. (2015) · Brain · doi:10.1093/brain/awv376 · Cited by 96 · see citing works
Neuron-to-neuron α-synuclein propagation in vivo is independent of neuronal injury
Ulusoy, A., Musgrove, R. E., Rusconi, R., Klinkenberg, M., Helwig, M., Schneider, A., & Monte, D. A. D. (2015) · Acta Neuropathologica Communications · doi:10.1186/s40478-015-0198-y · Cited by 91 · see citing works
Tolmachova, T., Tolmachov, O. E., Barnard, A. R., Silva, S. R. D., Lipinski, D. M., Walker, N. J., MacLaren, R. E., & Seabra, M. C. (2013) · Journal of Molecular Medicine · doi:10.1007/s00109-013-1006-4 · Cited by 92 · see citing works
Early necrosis and apoptosis of Schwann cells transplanted into the injured rat spinal cord
Hill, C. E., Hurtado, A., Blits, B., Bahr, B. A., Wood, P. M., Bunge, M. B., & Oudega, M. (2007) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2007.05771.x · Cited by 90 · see citing works
Recombinant Adeno-Associated Viral Vectors in the Nervous System
Burger, C., Nash, K., & Mandel, R. J. (2005) · Human Gene Therapy · doi:10.1089/hum.2005.16.781 · Cited by 110 · see citing works
Park, J., Murray, G. J., Limaye, A., Quirk, J. M., Gelderman, M. P., Brady, R. O., & Qasba, P. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0537900100 · Cited by 88 · see citing works
AAV vector development, back to the future
Suárez-Amarán, L., Song, L., Tretiakova, A. P., Mikhail, S., & Samulski, R. J. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.03.064 · Cited by 92 · see citing works
Li, G., Mobbs, C. V., & Scarpace, P. J. (2003) · Diabetes · doi:10.2337/diabetes.52.8.1951 · Cited by 87 · see citing works
Seppen, J., Bakker, C., de Jong, B., Kunne, C., van den Oever, K., Vandenberghe, K., de Waart, R. D., Twisk, J., & Bosma, P. J. (2006) · Molecular Therapy · doi:10.1016/j.ymthe.2006.01.014 · Cited by 87 · see citing works
Dana, H., Novák, O., Guardado-Montesino, M., Fransen, J. W., Hu, A., Borghuis, B. G., Guo, C., Kim, D. S., & Svoboda, K. (2018) · PLoS ONE · doi:10.1371/journal.pone.0205444 · Cited by 85 · see citing works
Kingsman, S. M., Mitrophanous, K., & Olsen, J. C. (2005) · Gene Therapy · doi:10.1038/sj.gt.3302417 · Cited by 84 · see citing works
Adenovirus Ubiquitin-Protein Ligase Stimulates Viral Late mRNA NuclearExport
Woo, J. L., & Berk, A. J. (2006) · Journal of Virology · doi:10.1128/jvi.01725-06 · Cited by 84 · see citing works
A lung tropic AAV vector improves survival in a mouse model of surfactant B deficiency
Kang, M. H., van Lieshout, L. P., Xu, L., Domm, J. M., Vadivel, A., Renesme, L., Mühlfeld, C., Hurskainen, M., Mižíková, I., Pei, Y., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-17577-8 · Cited by 85 · see citing works
CRM1-Dependent Function of a cis-Acting RNA Export Element
Popa, I., Harris, M. E., Donello, J. E., & Hope, T. J. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.7.2057-2067.2002 · Cited by 82 · see citing works
Self-citationWPRE-mediated enhancement of gene expression is promoter and cell line specific
Klein, R., Ruttkowski, B., Knapp, E., Salmons, B., Günzburg, W. H., & Hohenadl, C. (2006) · Gene · doi:10.1016/j.gene.2005.12.018 · Cited by 81 · see citing works
Ruitenberg, M. J., Blits, B., Dijkhuizen, P. A., Beek, E. T. T., Bakker, A., van Heerikhuize, J. J., Pool, C. W., Hermens, W. T. J., Boer, G. J., & Verhaagen, J. (2004) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.11.018 · Cited by 80 · see citing works
Jackson, K. L., Dayton, R. D., Orchard, E. A., Ju, S., Ringe, D., Petsko, G. A., Maquat, L. E., & Klein, R. L. (2014) · Gene Therapy · doi:10.1038/gt.2014.101 · Cited by 76 · see citing works
Nieuwenhuis, B., Laperrousaz, E., Tribble, J. R., Verhaagen, J., Fawcett, J. W., Martin, K. R. G., Williams, P. A., & Osborne, A. (2023) · Gene Therapy · doi:10.1038/s41434-022-00380-z · Cited by 77 · see citing works
Adeno-associated virus-mediated gene transfer to hair cells and support cells of the murine cochlea
Stone, I. M., Lurie, D. I., Kelley, M. W., & Poulsen, D. J. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.02.005 · Cited by 75 · see citing works
Liu, B., Paton, J. F. R., & Kasparov, S. (2008) · BMC Biotechnology · doi:10.1186/1472-6750-8-49 · Cited by 74 · see citing works
Chenuaud, P., Larcher, T., Rabinowitz, J. E., Provost, N., Joussemet, B., Bujard, H., Samulski, R. J., Moullier, P., & Favre, D. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2003.12.015 · Cited by 74 · see citing works
Long-term Amelioration of Feline Mucopolysaccharidosis VI After AAV-mediated Liver Gene Transfer
Cotugno, G., Annunziata, P., Tessitore, A., O’Malley, T. M., Capalbo, A., Faella, A., Bartolomeo, R., O’Donnell, P., Wang, P., Russo, F., et al. (2010) · Molecular Therapy · doi:10.1038/mt.2010.257 · Cited by 74 · see citing works
The L444P Gba1 mutation enhances alpha-synuclein induced loss of nigral dopaminergic neurons in mice
Migdalska‐Richards, A., Węgrzynowicz, M., Rusconi, R., Deangeli, G., Monte, D. A. D., Spillantini, M. G., & Schapira, A. H. V. (2017) · Brain · doi:10.1093/brain/awx221 · Cited by 73 · see citing works
Ruitenberg, M. J., Eggers, R., Boer, G. J., & Verhaagen, J. (2002) · Methods · doi:10.1016/s1046-2023(02)00222-0 · Cited by 72 · see citing works
Homs, J., Ariza, L., Pagès, G., Udina, E., Navarro, X., Chillón, M., & Bosch, A. (2011) · Gene Therapy · doi:10.1038/gt.2011.7 · Cited by 67 · see citing works
Retinal gene delivery by adeno-associated virus (AAV) vectors: Strategies and applications
Schön, C., Biel, M., & Michalakis, S. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.01.009 · Cited by 68 · see citing works
Rohll, J. B., Mitrophanous, K. A., Martin‐Rendon, E., Ellard, F. M., Radcliffe, P. A., Mazarakis, N. D., & Kingsman, S. M. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)46072-7 · Cited by 68 · see citing works
Central leptin gene therapy fails to overcome leptin resistance associated with diet-induced obesity
Wilsey, J. T., Zolotukhin, S., Prima, V., & Scarpace, P. J. (2003) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00193.2003 · Cited by 67 · see citing works
McCORMACK, W. M., Seiler, M. P., Bertin, T., UBHAYAKAR, K., Palmer, D. J., Ng, P., Nichols, T. C., & Lee, B. (2006) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2006.01901.x · Cited by 67 · see citing works
Scarpace, P. J., Matheny, M. E., Zhang, Y., Shek, E. W., Prima, V., Zolotukhin, S., & Tümer, N. (2002) · Endocrinology · doi:10.1210/endo.143.8.8966 · Cited by 67 · see citing works
Fitzsimons, H. L., McKenzie, J., & During, M. J. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301582 · Cited by 66 · see citing works
Neuroprotective Drug for Nerve Trauma Revealed Using Artificial Intelligence
Romeo-Guitart, D., Forés, J., Herrando-Grabulosa, M., Valls, R., Leiva-Rodríguez, T., Galea, E., González-Pérez, F., Navarro, X., Petegnief, V., Bosch, A., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-19767-3 · Cited by 71 · see citing works
Choroideremia: from genetic and clinical phenotyping to gene therapy and future treatments
Mitsios, A., Dubis, A. M., & Moosajee, M. (2018) · Therapeutic Advances in Ophthalmology · doi:10.1177/2515841418817490 · Cited by 62 · see citing works
Scarpace, P. J., Matheny, M. E., Zhang, Y., Tümer, N., Frase, C. D., Shek, E. W., Hong, B., Prima, V., & Zolotukhin, S. (2002) · Neuropharmacology · doi:10.1016/s0028-3908(02)00003-5 · Cited by 62 · see citing works
Gholizadeh, S., Tharmalingam, S., MacAldaz, M. E., & Hampson, D. R. (2013) · Human Gene Therapy Methods · doi:10.1089/hgtb.2013.076 · Cited by 61 · see citing works
Patrício, M. I., Barnard, A. R., Orlans, H. O., McClements, M. E., & MacLaren, R. E. (2017) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2016.12.006 · Cited by 59 · see citing works
Mian, A. I., McCormack, W. M., Mane, V. P., Kleppe, S., Ng, P., Finegold, M. J., O’Brien, W. E., Rodgers, J. R., Beaudet, A. L., & Lee, B. (2004) · Molecular Therapy · doi:10.1016/j.ymthe.2004.05.036 · Cited by 59 · see citing works
Gene Therapy for Choroideremia Using an Adeno-Associated Viral (AAV) VectorPreprint
Barnard, A. R., Groppe, M., & MacLaren, R. E. (2014) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a017293 · Cited by 60 · see citing works
Dreismann, A. K., McClements, M. E., Barnard, A. R., Orhan, E., Hughes, J. P., Lachmann, P. J., & MacLaren, R. E. (2021) · Gene Therapy · doi:10.1038/s41434-021-00239-9 · Cited by 58 · see citing works
Huda, F., Konno, A., Matsuzaki, Y., Goenawan, H., Miyake, K., Shimada, T., & Hirai, H. (2014) · Molecular Therapy — Methods & Clinical Development · doi:10.1038/mtm.2014.32 · Cited by 58 · see citing works
Palfi, A., Millington‐Ward, S., Chadderton, N., O’Reilly, M., Goldmann, T., Humphries, M. M., Li, T., Uwe Wolfrum, B., Humphries, P., Kenna, P. F., et al. (2009) · Human Gene Therapy · doi:10.1089/hum.2009.119 · Cited by 56 · see citing works
Esslinger, C. S., Agarwal, S. R., Gerdes, J. M., Wilson, P. A., Davis, E. S., Awes, A. N., O’Brien, E. M., Mavencamp, T., Koch, H. P., Poulsen, D. J., et al. (2005) · Neuropharmacology · doi:10.1016/j.neuropharm.2005.08.009 · Cited by 56 · see citing works
Mähönen, A. J., Airenne, K. J., Purola, S., Peltomaa, E., Kaikkonen, M. U., Riekkinen, M. S., Heikura, T., Kinnunen, K., Roschier, M. M., Wirth, T., et al. (2007) · Journal of Biotechnology · doi:10.1016/j.jbiotec.2007.05.022 · Cited by 56 · see citing works
Boulis, N. M., Noordmans, A. J., Song, D. K., Imperiale, M. J., Rubin, A. D., Leone, P., During, M. J., & Feldman, E. L. (2003) · Neurobiology of Disease · doi:10.1016/j.nbd.2003.08.025 · Cited by 56 · see citing works
Brun, S., Biguet, N. F., & Mallet, J. J. (2003) · Molecular Therapy · doi:10.1016/s1525-0016(03)00097-2 · Cited by 54 · see citing works
Li, G., Zhang, Y., Wilsey, J. T., & Scarpace, P. J. (2005) · Diabetologia · doi:10.1007/s00125-005-1943-8 · Cited by 54 · see citing works
Liu, Y.-L., Mingozzi, F., Rodriguez-Colon, S. M., Joseph, S. O., Dobrzynski, E., Suzuki, T., High, K. A., & Herzog, R. W. (2004) · Human Gene Therapy · doi:10.1089/1043034041648453 · Cited by 54 · see citing works
Harding, T., Koprivnikar, K., Tu, G., Zayek, N., Lew, S., Subramanian, A., Sivakumaran, A., Frey, D., Ho, K. I., VanRoey, M., et al. (2004) · Gene Therapy · doi:10.1038/sj.gt.3302142 · Cited by 53 · see citing works
Rapid Neurofibrillary Tangle Formation after Localized Gene Transfer of Mutated Tau
Klein, R. L., Lin, W.-L., Dickson, D. W., Lewis, J. M., Hutton, M. L., Duff, K., Meyer, E. M., & King, M. A. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63124-0 · Cited by 52 · see citing works
Weitz, A. C., Behrend, M. R., Lee, N. S., Klein, R. L., Chiodo, V. A., Hauswirth, W. W., Humayun, M. S., Weiland, J. D., & Chow, R. H.-P. (2013) · Journal of Neurophysiology · doi:10.1152/jn.00852.2012 · Cited by 51 · see citing works
Sweeney, C. L., Pavel-Dinu, M., Choi, U., Brault, J., Liu, T., Koontz, S. M., Li, L., Theobald, N., Lee, J., Bello, E. A., et al. (2021) · Gene Therapy · doi:10.1038/s41434-021-00251-z · Cited by 51 · see citing works
Promising and delivering gene therapies for vision loss
Carvalho, L. S., & Vandenberghe, L. H. (2014) · Vision Research · doi:10.1016/j.visres.2014.07.013 · Cited by 49 · see citing works
Mastroyiannopoulos, N. P., Feldman, M. L., Uney, J. B., Mahadevan, M. S., & Phylactou, L. A. (2005) · EMBO Reports · doi:10.1038/sj.embor.7400390 · Cited by 49 · see citing works
Xu, L., Yao, S., Ding, Y. E., Xie, M., Feng, D., Sha, P., Tan, L., Bei, F., & Yao, Y. (2024) · Journal of Translational Medicine · doi:10.1186/s12967-024-05661-2 · Cited by 48 · see citing works
Harding, T. C., Dickinson, P. J., Roberts, B. N., Yendluri, S., Gonzalez-Edick, M., Lecouteur, R. A., & Jooss, K. U. (2006) · Human Gene Therapy · doi:10.1089/hum.2006.17.807 · Cited by 45 · see citing works
Xu, Z., Mizuguchi, H., Mayumi, T., & Hayakawa, T. (2003) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/s0304-4165(03)00078-3 · Cited by 43 · see citing works
- Authors
- Loeb, J. E., Cordier, W. S., Harris, M. E., Weitzman, M. D., & Hope, T. J.
- Affiliations
- Salk Institute for Biological Studies (US)
- Venue
- Human Gene Therapy
- Publisher
- SAGE Publications
- Published
- 1999-09-20
- Volume
- 10
- Issue
- 14
- Pages
- 2295-2305
- ISSN
- 1043-0342 (ISSN-L)
- 1557-7422
- OpenAlex
- W2142334980
- Cited by
- 279
- References
- 35
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 18 · 2023: 8 · 2022: 10 · 2021: 15 · 2020: 11 · 2019: 7 · 2018: 7 · 2017: 10 · 2016: 5 · 2015: 10 · 2014: 11 · 2013: 6 · 2012: 6
- FWCI
- 5.23
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Human Gene Therapy (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Virus-based gene therapy research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Research and Splicing
- Keywords
- woodchuck hepatitis virus, adeno-associated virus vectors, green fluorescent protein, gene therapy, cis-acting regulation, stable transfection, transduction, human fibroblasts, long-term transgene expression
- MeSH terms
- Dependovirus, Cell Line, Flow Cytometry, Genetic Vectors, Humans, Luminescent Proteins, Regulatory Sequences, Nucleic Acid, RNA Processing, Post-Transcriptional, RNA, Viral, Blotting, Western, Gene Expression Regulation, Viral, Hepatitis B Virus, Woodchuck, Gene Transfer Techniques, Transgenes, Green Fluorescent Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review